Seres Therapeutics Financial Overview
Seres Therapeutics's market cap is currently €115.70M. The company's EPS TTM is €0.8032286369999999; its P/E ratio is ―; Seres Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is €-1.80. See an overview of income statement, balance sheet, and cash flow financials.
